Definium Therapeutics, Inc.

Healthcare

NASDAQ:DFTX · NASDAQ Global Select

Market Cap $2.66B Beta 2.38 P/E (TTM) -11.0

$24.48 -1.67%

-$0.41 today

52W Low $12.88High $26.15

Vol 1.68M · Avg 2.67M

EPS (TTM) -$2.18Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+268.12%

Period High

$24.75

Period Low

$6.49

Latest

$24.48

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Tango Therapeutics, Inc.

NASDAQ:TNGX

$3.61B

AnaptysBio, Inc.

NASDAQ:ANAB

$2.40B

Kodiak Sciences Inc.

NASDAQ:KOD

$1.91B

UroGen Pharma Ltd.

NASDAQ:URGN

$1.60B

Nurix Therapeutics, Inc.

NASDAQ:NRIX

$1.49B

Fortrea Holdings Inc.

NASDAQ:FTRE

$1.46B

Savara Inc.

NASDAQ:SVRA

$1.11B

Xencor, Inc.

NASDAQ:XNCR

$937.92M

BridgeBio Oncology Therapeutics Inc.

NASDAQ:BBOT

$605.61M

Rezolute, Inc.

NASDAQ:RZLT

$481.46M

What is the latest DFTX filing?

The latest filing shown is S-8 dated Jun 16, 2026.

How many recent filings does DFTX have?

Intrinsic Alpha currently shows 20 recent filings for DFTX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.